Skip to content
Disclosery

Skorpios Trust

Follow

13F filer, CIK 1869333, LIMASSOL, Cyprus

Skorpios Trust reported $46,062,839 across 2 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-06.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001123292-25-000200

Period
2025-03-31
Reported value
$46.1M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001123292-25-000200, largest first. % of portfolio is the value over $46,062,839, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 14,443,681 shares; 2024Q1: 14,443,681 shares; 2024Q2: 10,843,681 shares; 2024Q3: 8,906,181 shares; 2024Q4: 6,906,181 shares; 2025Q1: 6,906,181 shares 6,906,181$45.9M99.7%0Timeline
XBISPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,686 shares; 2024Q1: 1,686 shares; 2024Q2: 1,686 shares; 2024Q3: 1,686 shares; 2024Q4: 1,686 shares; 2025Q1: 1,686 shares 1,686$137K0.3%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001123292-25-000200 base2025-05-06acceptance time not in the bulk data set